Alida Griffith, MD
Neurology · Kirkland, WANPI 1861474793
Payments from drug & device makers
Across 194 payments — averaging $2632.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB SA$326K
- Sanofi$142K
- Sunovion Pharmaceuticals Inc.$30K
- H. Lundbeck A S$5K
- AbbVie$4K
- Jazz Pharmaceuticals Inc.$1K
- plus $3K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB SA | 19 | $326,151 |
| Sanofi | 21 | $141,926 |
| Sunovion Pharmaceuticals Inc. | 7 | $29,663 |
| H. Lundbeck A S | 5 | $5,054 |
| AbbVie(2 entities) | 14 | $4,267 |
| Jazz Pharmaceuticals Inc. | 1 | $1,000 |
| Novartis | 18 | $375 |
| Teva Pharmaceuticals USA, Inc. | 16 | $284 |
| Merz Pharmaceuticals, LLC | 8 | $220 |
| Abbott | 2 | $184 |
| Acadia Pharmaceuticals Inc | 8 | $162 |
| Johnson & Johnson | 4 | $120 |
| Merz North America, Inc. | 8 | $116 |
| TG Therapeutics, Inc. | 5 | $97 |
| Bristol Myers Squibb | 5 | $90 |
| Acorda Therapeutics, Inc | 4 | $83 |
| Boston Scientific | 4 | $82 |
| Neurocrine Biosciences, Inc. | 4 | $78 |
| Amneal Pharmaceuticals LLC | 4 | $76 |
| MDD US Operations, LLC | 5 | $75 |
| Neurelis, Inc. | 3 | $60 |
| Medtronic | 3 | $60 |
| SK Life Science, Inc. | 2 | $55 |
| UCB, Inc. | 2 | $46 |
| Eisai Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $45 |
| CSL Behring | 2 | $43 |
| Vertical Pharmaceuticals, LLC | 2 | $43 |
| Avanir Pharmaceuticals, Inc. | 2 | $40 |
| Genentech USA, Inc. | 2 | $33 |
| GE HealthCare | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Insightec,inc | 1 | $22 |
| Adamas Pharmaceuticals, Inc. | 1 | $21 |
| Cycle Pharmaceuticals Inc | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Argenx US, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$510,763 in reported general payments places this provider in the 95th percentile of 418 neurology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Kirkland
- Pinky AgarwalKirkland$5.4M
- James BowenKirkland$2.3M
- Daniel BurdickKirkland$1M
- Jason PoonKirkland$934K
- James SongKirkland$273K
- Jennifer WittKirkland$108K
- Arash FazlKirkland$71K
- Jason AldredSpokane$9.5M
- David GreeleySpokane$8.5M
- Pavle RepovicSeattle$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.